UVA test therapy uses microRNAs, nanoparticles and ultrasound against glioblastoma
Dr_Singularity · x · 2026-07-24
Researchers at UVA developed an experimental glioblastoma therapy that combines microRNAs, brain-penetrating nanoparticles, and focused ultrasound to shut down multiple cancer-driving genes at once.
- In animal studies, the approach slowed tumor growth and extended survival.
- The work targets glioblastoma, one of the deadliest brain cancers, and the delivery method is designed to help cargo reach the brain more effectively.
More from Research
- Peking University releases K12-KGraph, a 23,640-question benchmark for educational LLMs — PekingUniversity · 2026-07-24
- ACM CUI 2026 Best Paper goes to a paper on human-AI clones for museum science communication — HirokatuKataoka · 2026-07-24
- Robotics VLA inference work surfaces latency and action-chunking tradeoffs — SoyGema · 2026-07-24
- Synthesia co-founder Matt Niessner says world models are close to a breakthrough — HirokatuKataoka · 2026-07-24
- Agent searches may scale to 10,000 conjecture disproofs, but verification stays the bottleneck — JensHonack · 2026-07-24
- Ailin tests whether coordinated model teams can beat one bigger model — Resident-Log-4754 · 2026-07-24